KonsultIA.be
    💊
    For individuals

    Why use KonsultIA for Pharma & Biotech?

    Access expert advice without prohibitive fees. Your personal AI assistant, 24/7.

    Try for freeView pricing
    As an individual, you often encounter these frustrations.

    The challenges you face

    💊

    Incomprehensible NIHDI reimbursements

    Categories A, B, C, Cs, co-payment, BIM status — you don't understand what you pay and what's reimbursed.

    💸

    Cheaper generics ignored

    Reimbursed generic alternatives exist for many medicines but neither your doctor nor pharmacist systematically offers them.

    📋

    Patient rights poorly known

    BIM status, maximum billing (MAF), third-party payment, global medical file — dozens of rights exist but remain unknown.

    Powerful AI tools, specialized in Belgium's regulatory context.

    How KonsultIA solves these problems

    💬
    KonsultIA tool: Chat Expert

    Reimbursement and pharma rights guide

    PharmaPro explains NIHDI reimbursement categories, BIM status, MAF and all your rights as a Belgian patient.

    Try for free
    🔍
    KonsultIA tool: Audit Conformité

    Health reimbursement audit

    Check if you qualify for BIM status, MAF, third-party payment and discover your medicines' reimbursement categories.

    Try for free
    📄
    KonsultIA tool: Générateur Documents

    Reimbursement requests and forms

    Generate chapter IV special reimbursement requests, BIM status application, third-party payment form and health fund appeal.

    Try for free
    Average results observed among our Belgian users.

    The concrete impact on your activity

    Generic savings/yearBIM status activatedKnown health rightsOptimized reimbursements/year0200400600800
    • Before
    • With KonsultIA

    Generic savings/year

    0€480€

    BIM status activated

    0%100%

    Known health rights

    20%90%

    Optimized reimbursements/year

    0€650€

    Real-world example

    Discover how KonsultIA transforms everyday life.

    Martine, 62, retiree in Namur with 4 daily medicines

    Situation

    Martine was paying full price on her medicines without knowing she was eligible for BIM status. She didn't know about reimbursed generic alternatives.

    KonsultIA solution

    PharmaPro identified her BIM eligibility, explained generics exist for her medicines (to validate with her pharmacist) and an unclaimed chapter IV reimbursement. Forms were auto-generated.

    Results

    • BIM status activated: 25% higher reimbursements
    • Potential savings identified with her pharmacist
    • Chapter IV reimbursement obtained (€170/year)
    • All patient rights identified and activated

    Key benefits

    NIHDI reimbursements explained simply (categories A/B/C)
    Generic information to discuss with your pharmacist
    BIM status and MAF auto-checked
    Chapter IV reimbursement forms generated
    Belgian patient rights clearly explained
    Concrete savings on your health reimbursements

    Ready to transform your Pharma & Biotech?

    Join the Belgian users who trust KonsultIA.

    Create my free accountView pricing